Managing sodium levels in patients with severe kidney disease
Official title: Regulation of Extracellular Sodium in End Stage Renal Disease Upon Volume and Electrolyte Challenges - a Prospective Trial.
Run by University of Cologne · NCT06408077 · Data updated 2026-11-12
This study tests how giving water and salt to adults with severe kidney disease can help balance their sodium levels and improve their health.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | University of Cologne Academic / other |
| Locations | 1 site (Cologne) |
| Status | Recruiting |
| Started | July 1, 2023 |
| Main results expected | May 31, 2026 |
| Study ends | May 31, 2026 |
| Registry record updated | September 17, 2025 |
| Trial ID | NCT06408077 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults aged 18 and older who require renal replacement therapy and have stable hemodialysis treatment.
✕Probably not a fit
Patients on peritoneal dialysis or those with acute illnesses or significant comorbidities may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the regulation of extracellular sodium levels in patients with end-stage renal disease who are undergoing volume and electrolyte challenges. It focuses on the effects of water and sodium chloride administration on patients with hyponatremia, a common electrolyte disorder. By monitoring intracellular measurements, the study aims to understand how these interventions can restore osmotic balance and improve patient outcomes. The research targets adult patients requiring renal replacement therapy and aims to provide insights into effective management strategies for electrolyte imbalances.
Why it matters
Potential benefit: If successful, this study could lead to improved management of hyponatremia in patients with end-stage renal disease, potentially reducing complications and enhancing quality of life.
How similar studies have gone: While there have been studies addressing electrolyte imbalances, this specific approach focusing on sodium regulation in end-stage renal disease is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult patients ≥18 years * Requirement of renal replacement therapy due to surgical (i.e., nephrectomy) or non-surgical (chronic kidney disease) reason * Stable hemodialysis treatment for at least 3 months * Urine output \<100ml in 24 hours * Glucose-corrected plasma sodium between 135 mmol/l and 145 mmol/l * Plasma potassium between 3.5 mmol/l and 5 mmol/l * Written informed consent Exclusion Criteria: * Peritoneal dialysis patients * Signs of volume expansion or contraction * Congestive heart failure (NYHA ≥2) * acute illness (infection, congestive heart failure, liver cirrhosis, etc.) requiring hospital admission * Uncontrolled arterial hypertension * Hemoglobin ≤8g/dL * Alcohol abuse * Malnutrition * Persons, who are in a dependency/employment relationship with the investigators * Accommodation in an institution by judicial or administrative order
Where it's running
-
Department II of Internal Medicine,University of Cologne
Cologne, Germany Recruiting
Study contacts
- Principal investigator: Volker Burst, MD — University Hospital of Cologne
- Study coordinator: Volker Burst, MD
- Email: volker.burst@uk-koeln.de
- Phone: +49 221 478 86285
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Preventing low blood sodium after pituitary surgery with extra protein or fluid restriction
This study tests whether taking extra dietary protein or temporarily limiting fluids after pituitary surgery helps prevent low blood sodium (hyponatremia) in adults.
-
Protein supplementation for treating low sodium levels in hospitalized patients
This study is testing if giving extra protein to hospitalized patients with low sodium levels works better and is more acceptable than limiting their fluid intake.
-
Using DDAVP to prevent sodium overcorrection in severe hyponatremia
This study is testing if adding a medication called DDAVP to standard treatment can help ICU patients with severe low sodium levels avoid dangerous complications from rapid sodium changes.
-
New diagnostic methods for treating low sodium levels in patients on thiazide diuretics
This study is testing two new ways to help doctors figure out why patients on thiazide diuretics have low sodium levels, to see if it can lead to better treatment options.
-
Investigating urinary prostaglandin levels to predict thiazide-induced low sodium levels
This study is trying to see if measuring a specific substance in urine can help predict if people starting thiazide diuretics will develop low sodium levels.
-
Evaluating electrolyte balance in hyponatremia treatment
This study is trying to see how different treatments for low sodium levels in the blood affect electrolyte balance and fluid changes in patients with hyponatremia.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.